Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024

Joshua Brody shared on LinkedIn:

“Excited for the Amps-to-go-up-to-11 at tomorrow’s CME event on CAR T-cell therapy for lymphoma and CLL with Research To Practice, Jason Westin, and Matt Lunning at SOHO2024!”

Read Further.
Source: Joshua Brody/LinkedIn

Joshua Brody, MD, is the Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai and a faculty member at the Icahn Genomics Institute. He has established a comprehensive clinical program and a Cancer Immunotherapy Lab focused on basic and applied tumor immunology. His lab investigates novel therapies for lymphomas, breast cancer, and head/neck cancer, with results published in leading scientific journals.